Paradigm Capital Management Inc. NY Buys New Position in OrthoPediatrics Corp. $KIDS

Paradigm Capital Management Inc. NY bought a new position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) during the second quarter, HoldingsChannel reports. The institutional investor bought 47,000 shares of the company’s stock, valued at approximately $899,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of KIDS. Millennium Management LLC lifted its holdings in OrthoPediatrics by 48.0% in the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock valued at $24,802,000 after acquiring an additional 452,840 shares during the last quarter. BlackRock Inc. bought a new position in shares of OrthoPediatrics during the 2nd quarter valued at about $24,347,000. Vanguard Group Inc. grew its stake in shares of OrthoPediatrics by 1.1% in the 3rd quarter. Vanguard Group Inc. now owns 961,330 shares of the company’s stock worth $17,813,000 after purchasing an additional 10,927 shares during the last quarter. Granahan Investment Management LLC raised its holdings in shares of OrthoPediatrics by 35.1% in the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock worth $14,231,000 after purchasing an additional 232,760 shares in the last quarter. Finally, Wasatch Advisors LP raised its holdings in shares of OrthoPediatrics by 56.6% in the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock worth $9,865,000 after purchasing an additional 186,357 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently commented on the stock. Weiss Ratings raised shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. Needham & Company LLC lifted their price target on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. TD Cowen reaffirmed a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. Truist Financial set a $22.00 price objective on OrthoPediatrics in a research report on Wednesday, August 5th. Finally, Piper Sandler reiterated an “overweight” rating and set a $25.00 price objective (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Nine equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $26.44.

OrthoPediatrics Stock Performance

Shares of OrthoPediatrics stock opened at $25.07 on Tuesday. The stock has a market cap of $654.58 million, a PE ratio of -14.92 and a beta of 0.98. The business has a fifty day simple moving average of $20.99 and a 200-day simple moving average of $18.47. The company has a quick ratio of 2.17, a current ratio of 4.78 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a 12 month low of $14.42 and a 12 month high of $26.74.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, beating the consensus estimate of ($0.30) by $0.04. The firm had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%. On average, sell-side analysts anticipate that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.